Blundering hospital medics who failed to spot cancer cost the NHS £46.9million in compensation

The figures mean that in an average week NHS hospitals are making three potentially fatal cancer diagnosis blunders. The 545 cancer mistakes cost the NHS an average payout of almost £90,000.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

LUNG cancer symptoms include a cough the won ’t go away, unexplained weight loss and severe chest pain. But you could also be at risk of deadly lung tumour signs if your eyes are a distinctive colour.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
While medicine transforms cancer into a chronic disease with which patients can live for an extended period of time, financial toxicity threatens to turn chronic, too.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Health Insurance and Managed Care Drugs (Pharmaceuticals) Bankruptcies Cancer Source Type: news
Elisa Boldrin, Sandro Malacrida, Enrica Rumiato, Giorgio Battaglia, Alberto Ruol, Alberto Amadori, Daniela Saggioro
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Chin-Yap Loh, Aditya Arya, Ahmed Fadhil Naema, Won Fen Wong, Gautam Sethi, Chung Yeng Looi
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Vincenzo Ingangi, Michele Minopoli, Concetta Ragone, Maria Letizia Motti, Maria Vincenza Carriero
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Source: Lung Cancer - Category: Cancer & Oncology Source Type: research
Source: Lung Cancer - Category: Cancer & Oncology Source Type: research
A new study from the CDC found cases of women positive for HPV types 16 and 18 - responsible for about 70% of cervical cancers worldwide - fell by more than 30% from 2008 to 2014.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
In HIV-infected patients with a variety of advanced cancers, immune-checkpoint inhibitors (ICIs) appear to be effective and add no new risks, according to a new systematic review.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Hematology-Oncology News Source Type: news
The company said in a regulatory filing that it had received subpoenas from the Justice Department and the Securities and Exchange Commission related to its talc-based products.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Hazardous and Toxic Substances Regulation and Deregulation of Industry Drugs (Pharmaceuticals) Asbestos Johnson & Justice Department Securities and Exchange Commission Ovarian Cancer Suits and Litigation (Civil) Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hospitals